These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22739143)

  • 21. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.
    Sadan O; Melamed E; Offen D
    Expert Opin Biol Ther; 2009 Dec; 9(12):1487-97. PubMed ID: 19821796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combined artificial chromosome-stem cell therapy method in a model experiment aimed at the treatment of Krabbe's disease in the Twitcher mouse.
    Katona RL; Sinkó I; Holló G; Szucs KS; Praznovszky T; Kereso J; Csonka E; Fodor K; Cserpán I; Szakál B; Blazsó P; Udvardy A; Hadlaczky G
    Cell Mol Life Sci; 2008 Nov; 65(23):3830-8. PubMed ID: 18850314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to human's].
    Nadal-Ginard B; Torella D; Ellison G
    Rev Esp Cardiol; 2006 Nov; 59(11):1175-89. PubMed ID: 17144992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted gene modification for gene therapy of stem cells.
    Boggs SS
    Int J Cell Cloning; 1990 Mar; 8(2):80-96. PubMed ID: 1968938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fanconi anemia and beta c deficiency-associated pulmonary alveolar proteinosis as two hereditary diseases of childhood which are potentially curable by stem cell gene therapy but require different therapeutic approaches.
    Dirksen U; Moritz T; Burdach S; Flasshove M; Hanenberg H
    Klin Padiatr; 1999; 211(4):329-35. PubMed ID: 10472572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic use of stem cells. II. Adult stem cells].
    Uzan G
    Rev Prat; 2004 Sep; 54(14):1515-27. PubMed ID: 15558959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic therapies for cardiovascular diseases.
    Melo LG; Pachori AS; Gnecchi M; Dzau VJ
    Trends Mol Med; 2005 May; 11(5):240-50. PubMed ID: 15882612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current status of gene therapy in autologous transplantation.
    Becker PS
    Acta Haematol; 2005; 114(4):188-97. PubMed ID: 16269858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene targeting for gene therapy: prospects.
    Lanzov VA
    Mol Genet Metab; 1999 Oct; 68(2):276-82. PubMed ID: 10527679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy in transplantation: Toward clinical trials.
    Ritter T; Nosov M; Griffin MD
    Curr Opin Mol Ther; 2009 Oct; 11(5):504-12. PubMed ID: 19806498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipose-derived stem and stromal cells for cell-based therapy: current status of preclinical studies and clinical trials.
    Mizuno H
    Curr Opin Mol Ther; 2010 Aug; 12(4):442-9. PubMed ID: 20677095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].
    Brito C; Simão D; Costa I; Malpique R; Pereira CI; Fernandes P; Serra M; Schwarz SC; Schwarz J; Kremer EJ; Alves PM
    Methods; 2012 Mar; 56(3):452-60. PubMed ID: 22433395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced pluripotent stem cells and severe combined immunodeficiency: merely disease modeling or potentially a novel cure?
    Mikkers H; Pike-Overzet K; Staal FJ
    Pediatr Res; 2012 Apr; 71(4 Pt 2):427-32. PubMed ID: 22430378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus for neurodegenerative diseases: in vivo strategies and ex vivo gene therapy using human neural progenitors.
    Sabaté O; Barkats M; Buc-Caron MH; Castel-Barthe MN; Finiels F; Horellou P; Revah F; Mallet J
    Clin Neurosci; 1995-1996; 3(5):317-21. PubMed ID: 8914799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined gene and stem cell therapy for cutaneous wound healing.
    Gauglitz GG; Jeschke MG
    Mol Pharm; 2011 Oct; 8(5):1471-9. PubMed ID: 21657247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene targeting of human pluripotent stem cells by homologous recombination.
    Howden SE; Thomson JA
    Methods Mol Biol; 2014; 1114():37-55. PubMed ID: 24557896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Orphan Drug Act and the development of stem cell-based products for rare diseases.
    Freeman SN; Burke KA; Imoisili MA; Coté TR
    Cell Stem Cell; 2010 Sep; 7(3):283-7. PubMed ID: 20804965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders.
    Qin Y; Gao WQ
    Stem Cells; 2016 Jan; 34(1):44-54. PubMed ID: 26227066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.